MedPath

Inflammatory Markers: HOLEP Versus TURP

Not Applicable
Completed
Conditions
Prostate Hyperplasia
Registration Number
NCT05108662
Lead Sponsor
Adana City Training and Research Hospital
Brief Summary

Aim of the study is to compare the systemic inflammatory markers and surgical stress response in patients undergoing HOLEP or TUR-P surgery.

Detailed Description

Benign prostatic hyperplasia (BPH) is the most common disease in aging men worldwide, causing significant difficulties and resulting in bladder outlet obstruction. Basically, surgical techniques in patients with BPH are transurethral resection of the prostate (TURP), holmium laser enucleation of the prostate (HOLEP), and open prostoactemy surgery. There are many studies comparing the clinical outcomes of TURP and HOLEP surgery. However, to the best of our knowledge, there has not been a study comparing the effects of these two types of surgery on inflammatory markers and stress hormones.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
50
Inclusion Criteria
  • ASA scores I-III patients
  • having benign prostatic hyperplasia
  • undergoing HOLEP or TURP surgery under general anesthesia
Exclusion Criteria
  • immune system disease,
  • diabetes mellitus,
  • malignancy other than prostate disease,
  • history of steroid use,

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
inflamatory markersChange from baseline CD4+/CD8+ at postoperative 0th and postoperative 24th hourL-6 (pg/ml) and TNF-alfa (pg/ml)

CD4+/CD8+

Stress hormone levelsChange from baseline adrenaline (ng/L) at postoperative 0th and postoperative 24th hour

Adrenaline (ng/L)

stress hormone levelsChange from baseline cortisol (microg/dl) at postoperative 0th and postoperative 24th hour

Cortisol (microg/dl)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Adana City Training and Research Hospital

🇹🇷

Adana, Turkey

Adana City Training and Research Hospital
🇹🇷Adana, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.